111 related articles for article (PubMed ID: 2177607)
1. Nodular hepatocellular carcinoma--treatment with intraarterial injection of I-131 Lipiodol.
Yoo HS; Suh JH; Lee JT; Kim KW; Kim DI; Kim BS; Choi HJ; Lee KS
J Korean Med Sci; 1990 Jun; 5(2):75-83. PubMed ID: 2177607
[TBL] [Abstract][Full Text] [Related]
2. Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Yoo HS; Lee JT; Kim KW; Kim BS; Choi HJ; Lee KS; Park CI; Park CY; Suh JH; Loh JJ
Cancer; 1991 Nov; 68(9):1878-84. PubMed ID: 1717129
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
[TBL] [Abstract][Full Text] [Related]
4. Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma.
Maini CL; Scelsa MG; Fiumara C; Tofani A; Sciuto R; Tipaldi L; D'Annibale M; Santoro E
Clin Nucl Med; 1996 Mar; 21(3):221-6. PubMed ID: 8846568
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
[TBL] [Abstract][Full Text] [Related]
6. [Lipiodolized angiography in hepatocellular carcinomas. Contribution of iodine-131-labelled lipiodol].
Raoul JL; Duvauferrier R; Bourguet P; Bretagne JF; Coornaert S; Darnault P; Deugnier Y; Herry JY; Gastard J
J Radiol; 1986 Nov; 67(11):797-801. PubMed ID: 3027321
[TBL] [Abstract][Full Text] [Related]
7. Intraarterial HCC therapy with I-131-Lipiodol.
Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
[TBL] [Abstract][Full Text] [Related]
8. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma.
Raoul JL; Bretagne JF; Bourguet P; Duvauferrier R
Invest Radiol; 1996 May; 31(5):305-7. PubMed ID: 8724131
[TBL] [Abstract][Full Text] [Related]
9. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
[TBL] [Abstract][Full Text] [Related]
10. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
[TBL] [Abstract][Full Text] [Related]
11. 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma.
Toubeau M; Touzery C; Berriolo-Riedinger A; Cochet A; Brunotte F; Bedenne L; Cercueil JP; Krause D
Eur J Nucl Med; 2001 May; 28(5):669-70. PubMed ID: 11383874
[No Abstract] [Full Text] [Related]
12. Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow.
de Baere T; Taourel P; Tubiana JM; Kuoch V; Ducreux M; Lumbroso J; Roche AJ
Radiology; 1999 Sep; 212(3):665-8. PubMed ID: 10478229
[TBL] [Abstract][Full Text] [Related]
13. Small hepatocellular carcinoma: high dose internal radiation therapy with superselective intra-arterial injection of I-131-labeled Lipiodol.
Yoo HS; Park CH; Lee JT; Kim KW; Yoon CS; Suh JH; Park CY; Kim BS; Choi HJ; Lee KS
Cancer Chemother Pharmacol; 1994; 33 Suppl():S128-33. PubMed ID: 8137473
[TBL] [Abstract][Full Text] [Related]
14. Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.
Bhattacharya S; Dusheiko GM
Princess Takamatsu Symp; 1995; 25():253-64. PubMed ID: 8875631
[TBL] [Abstract][Full Text] [Related]
15. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
Novell JR; Hilson AJ
J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
[No Abstract] [Full Text] [Related]
16. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY; Lai EC; Leung TW; Yu SC
Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
[TBL] [Abstract][Full Text] [Related]
17. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of hepatic carcinoma by the intra-arterial injection of lipiodol, antineoplastic agents and gelfoam].
Rossi P; Salvatori FM; D'Erme M; Maradei A; Rossi M; Santoro P; Mastantuono M; Gualdi G
Radiol Med; 1989; 77(1-2):37-43. PubMed ID: 2538865
[TBL] [Abstract][Full Text] [Related]
19. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
20. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
